Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Golden Cross macht sich bereit: 1.350 Goldabbaustellen, 55 Ladder-Ziele und ein historischer Volltreffer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQGU | ISIN: CA4236943060 | Ticker-Symbol: 2VF0
Stuttgart
03.10.25 | 19:05
0,060 Euro
+6,19 % +0,004
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOSTEMIX INC Chart 1 Jahr
5-Tage-Chart
HEMOSTEMIX INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0630,07003.10.
0,0630,06903.10.

Aktuelle News zur HEMOSTEMIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.09.Hemostemix Inc (2): Hemostemix files FDA trial for ACP-01 stem therapy2
23.09.Hemostemix Inc.: Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell) Across Multiple Ischemic and Vascular Indications Simultaneously313Calgary, Alberta--(Newsfile Corp. - September 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
17.09.Hemostemix Inc.: Hemostemix to Present at Life Science Investor Forum155Calgary, Alberta--(Newsfile Corp. - September 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
16.09.Hemostemix Inc.: Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina318Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
HEMOSTEMIX Aktie jetzt für 0€ handeln
12.09.Hemostemix Inc (2): Hemostemix two million shares for debt2
11.09.Hemostemix Inc (2): Hemostemix to issue two million shares for debt2
10.09.Hemostemix Inc.: Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share408Calgary, Alberta--(Newsfile Corp. - September 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Company"), the leading autologous (patient's own) stem cell therapy company offering...
► Artikel lesen
10.09.Hemostemix Inc (2): Hemostemix arranges $280,594 private placement2
09.09.Hemostemix Inc (2): Hemostemix launches corporate website1
09.09.Hemostemix announces $280K non-brokered private placement3
09.09.Hemostemix Inc.: Hemostemix Announces Private Placement285Calgary, Alberta--(Newsfile Corp. - September 9, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
09.09.Hemostemix Inc.: Hemostemix Launches Enhanced HubSpot-Powered Websites to Support Global Marketing & Sales of ACP-01 for No-Option Patients305Calgary, Alberta--(Newsfile Corp. - September 9, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
05.09.Hemostemix Inc (2): Hemostemix rolls out VesCell.Health in Florida2
04.09.Hemostemix Inc.: Hemostemix's VesCell.Health Launched in Florida336Calgary, Alberta--(Newsfile Corp. - September 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
04.09.Hemostemix Inc (2): Hemostemix cheers 17 "years of line gained" by Lindeman16
03.09.Hemostemix Inc.: Howie's 17+ Years After VesCell: Following Hemostemix's Heart Patients317Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)...
► Artikel lesen
29.08.Hemostemix Inc (2): Hemostemix arranges payment plans for VesCell treatment14
28.08.Hemostemix Inc.: Hemostemix Announces Financing Plans for VesCell Treatment356Calgary, Alberta--(Newsfile Corp. - August 28, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous (patient's own) stem cell therapy company offering VesCell (ACP-01) to...
► Artikel lesen
27.08.Hemostemix Inc (2): Hemostemix begins face-to-face sales program in Florida2
26.08.Hemostemix Inc.: Hemostemix's Boots on the Ground in Florida340Calgary, Alberta--(Newsfile Corp. - August 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous (patient's own) stem cell therapy company offering VesCell (ACP-01) to...
► Artikel lesen
Weiter >>
85 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1